India’s drug regulator has identified 53 drugs, including supplements and medications for diabetes and high blood pressure, as ‘Not of Standard Quality.’ These drugs are produced by several pharmaceutical companies. Some firms have denied responsibility, calling the products spurious. In August, the CDSCO banned over 156 fixed-dose combinations.Major pharma firms in India under scrutiny
India’s drug regulator has identified 53 drugs, including supplements and medications for diabetes and high blood pressure, as ‘Not of Standard Quality.’ These drugs are produced by several pharmaceutical companies. Some firms have denied responsibility, calling the products spurious. In August, the CDSCO banned over 156 fixed-dose combinations.
